TZOUMAKAS KIMBERLY JO 4/A
4/A · Coherus BioSciences, Inc. · Filed Feb 11, 2022
Insider Transaction Report
Form 4/AAmended
TZOUMAKAS KIMBERLY JO
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-01-07+27,000→ 27,000 totalExercise: $14.67Exp: 2032-01-07→ Common Stock (27,000 underlying)
Footnotes (2)
- [F1]The Form 4/A is being filed solely to correct a typographical error in the exercise price. Except as noted in this footnote, all other information as disclosed in the Reporting Person's original Form 4 was accurately reported.
- [F2]The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.